Global Noninvasive Vaccination Market Research Report 2024(Status and Outlook)
Report Overview:
Noninvasive vaccine delivery systems need to incorporate an effective adjuvant, specially designed for triggering both mucosal and systemic immune responses.
The Global Noninvasive Vaccination Market Size was estimated at USD 2824.91 million in 2023 and is projected to reach USD 3917.31 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global Noninvasive Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Noninvasive Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Noninvasive Vaccination market in any manner.
Global Noninvasive Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
AstraZeneca
Cipla
BCHT
Market Segmentation (by Type)
Oral Vaccine
Nasal Spray Vaccine
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Noninvasive Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Noninvasive vaccine delivery systems need to incorporate an effective adjuvant, specially designed for triggering both mucosal and systemic immune responses.
The Global Noninvasive Vaccination Market Size was estimated at USD 2824.91 million in 2023 and is projected to reach USD 3917.31 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global Noninvasive Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Noninvasive Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Noninvasive Vaccination market in any manner.
Global Noninvasive Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
AstraZeneca
Cipla
BCHT
Market Segmentation (by Type)
Oral Vaccine
Nasal Spray Vaccine
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Noninvasive Vaccination Market
- Overview of the regional outlook of the Noninvasive Vaccination Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Noninvasive Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Noninvasive Vaccination
1.2 Key Market Segments
1.2.1 Noninvasive Vaccination Segment by Type
1.2.2 Noninvasive Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NONINVASIVE VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Noninvasive Vaccination Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Noninvasive Vaccination Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NONINVASIVE VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Noninvasive Vaccination Sales by Manufacturers (2019-2024)
3.2 Global Noninvasive Vaccination Revenue Market Share by Manufacturers (2019-2024)
3.3 Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Vaccination Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Noninvasive Vaccination Sales Sites, Area Served, Product Type
3.6 Noninvasive Vaccination Market Competitive Situation and Trends
3.6.1 Noninvasive Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NONINVASIVE VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Noninvasive Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NONINVASIVE VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NONINVASIVE VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Vaccination Sales Market Share by Type (2019-2024)
6.3 Global Noninvasive Vaccination Market Size Market Share by Type (2019-2024)
6.4 Global Noninvasive Vaccination Price by Type (2019-2024)
7 NONINVASIVE VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Vaccination Market Sales by Application (2019-2024)
7.3 Global Noninvasive Vaccination Market Size (M USD) by Application (2019-2024)
7.4 Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2024)
8 NONINVASIVE VACCINATION MARKET SEGMENTATION BY REGION
8.1 Global Noninvasive Vaccination Sales by Region
8.1.1 Global Noninvasive Vaccination Sales by Region
8.1.2 Global Noninvasive Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Noninvasive Vaccination Basic Information
9.1.2 Merck Noninvasive Vaccination Product Overview
9.1.3 Merck Noninvasive Vaccination Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Noninvasive Vaccination SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Noninvasive Vaccination Basic Information
9.2.2 GSK Noninvasive Vaccination Product Overview
9.2.3 GSK Noninvasive Vaccination Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Noninvasive Vaccination SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Noninvasive Vaccination Basic Information
9.3.2 Sanofi Noninvasive Vaccination Product Overview
9.3.3 Sanofi Noninvasive Vaccination Product Market Performance
9.3.4 Sanofi Noninvasive Vaccination SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Noninvasive Vaccination Basic Information
9.4.2 Lanzhou Institute Noninvasive Vaccination Product Overview
9.4.3 Lanzhou Institute Noninvasive Vaccination Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Noninvasive Vaccination Basic Information
9.5.2 Serum Institute Noninvasive Vaccination Product Overview
9.5.3 Serum Institute Noninvasive Vaccination Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Noninvasive Vaccination Basic Information
9.6.2 Valneva Noninvasive Vaccination Product Overview
9.6.3 Valneva Noninvasive Vaccination Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Noninvasive Vaccination Basic Information
9.7.2 Shanghai United Cell Noninvasive Vaccination Product Overview
9.7.3 Shanghai United Cell Noninvasive Vaccination Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Noninvasive Vaccination Basic Information
9.8.2 Bibcol Noninvasive Vaccination Product Overview
9.8.3 Bibcol Noninvasive Vaccination Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Noninvasive Vaccination Basic Information
9.9.2 PaxVax Noninvasive Vaccination Product Overview
9.9.3 PaxVax Noninvasive Vaccination Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Noninvasive Vaccination Basic Information
9.10.2 Vabiotech Noninvasive Vaccination Product Overview
9.10.3 Vabiotech Noninvasive Vaccination Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Noninvasive Vaccination Basic Information
9.11.2 Tiantan Biological Noninvasive Vaccination Product Overview
9.11.3 Tiantan Biological Noninvasive Vaccination Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Noninvasive Vaccination Basic Information
9.12.2 EuBiologics Noninvasive Vaccination Product Overview
9.12.3 EuBiologics Noninvasive Vaccination Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Noninvasive Vaccination Basic Information
9.13.2 Panacea Biotec Ltd Noninvasive Vaccination Product Overview
9.13.3 Panacea Biotec Ltd Noninvasive Vaccination Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Noninvasive Vaccination Basic Information
9.14.2 Bio-Med Noninvasive Vaccination Product Overview
9.14.3 Bio-Med Noninvasive Vaccination Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9.16 AstraZeneca
9.16.1 AstraZeneca Noninvasive Vaccination Basic Information
9.16.2 AstraZeneca Noninvasive Vaccination Product Overview
9.16.3 AstraZeneca Noninvasive Vaccination Product Market Performance
9.16.4 AstraZeneca Business Overview
9.16.5 AstraZeneca Recent Developments
9.17 Cipla
9.17.1 Cipla Noninvasive Vaccination Basic Information
9.17.2 Cipla Noninvasive Vaccination Product Overview
9.17.3 Cipla Noninvasive Vaccination Product Market Performance
9.17.4 Cipla Business Overview
9.17.5 Cipla Recent Developments
9.18 BCHT
9.18.1 BCHT Noninvasive Vaccination Basic Information
9.18.2 BCHT Noninvasive Vaccination Product Overview
9.18.3 BCHT Noninvasive Vaccination Product Market Performance
9.18.4 BCHT Business Overview
9.18.5 BCHT Recent Developments
10 NONINVASIVE VACCINATION MARKET FORECAST BY REGION
10.1 Global Noninvasive Vaccination Market Size Forecast
10.2 Global Noninvasive Vaccination Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Noninvasive Vaccination Market Size Forecast by Country
10.2.3 Asia Pacific Noninvasive Vaccination Market Size Forecast by Region
10.2.4 South America Noninvasive Vaccination Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Vaccination by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Noninvasive Vaccination Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Noninvasive Vaccination by Type (2025-2030)
11.1.2 Global Noninvasive Vaccination Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Noninvasive Vaccination by Type (2025-2030)
11.2 Global Noninvasive Vaccination Market Forecast by Application (2025-2030)
11.2.1 Global Noninvasive Vaccination Sales (Kilotons) Forecast by Application
11.2.2 Global Noninvasive Vaccination Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Noninvasive Vaccination
1.2 Key Market Segments
1.2.1 Noninvasive Vaccination Segment by Type
1.2.2 Noninvasive Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NONINVASIVE VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Noninvasive Vaccination Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Noninvasive Vaccination Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NONINVASIVE VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Noninvasive Vaccination Sales by Manufacturers (2019-2024)
3.2 Global Noninvasive Vaccination Revenue Market Share by Manufacturers (2019-2024)
3.3 Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Vaccination Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Noninvasive Vaccination Sales Sites, Area Served, Product Type
3.6 Noninvasive Vaccination Market Competitive Situation and Trends
3.6.1 Noninvasive Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NONINVASIVE VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Noninvasive Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NONINVASIVE VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NONINVASIVE VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Vaccination Sales Market Share by Type (2019-2024)
6.3 Global Noninvasive Vaccination Market Size Market Share by Type (2019-2024)
6.4 Global Noninvasive Vaccination Price by Type (2019-2024)
7 NONINVASIVE VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Vaccination Market Sales by Application (2019-2024)
7.3 Global Noninvasive Vaccination Market Size (M USD) by Application (2019-2024)
7.4 Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2024)
8 NONINVASIVE VACCINATION MARKET SEGMENTATION BY REGION
8.1 Global Noninvasive Vaccination Sales by Region
8.1.1 Global Noninvasive Vaccination Sales by Region
8.1.2 Global Noninvasive Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Noninvasive Vaccination Basic Information
9.1.2 Merck Noninvasive Vaccination Product Overview
9.1.3 Merck Noninvasive Vaccination Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Noninvasive Vaccination SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Noninvasive Vaccination Basic Information
9.2.2 GSK Noninvasive Vaccination Product Overview
9.2.3 GSK Noninvasive Vaccination Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Noninvasive Vaccination SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Noninvasive Vaccination Basic Information
9.3.2 Sanofi Noninvasive Vaccination Product Overview
9.3.3 Sanofi Noninvasive Vaccination Product Market Performance
9.3.4 Sanofi Noninvasive Vaccination SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Noninvasive Vaccination Basic Information
9.4.2 Lanzhou Institute Noninvasive Vaccination Product Overview
9.4.3 Lanzhou Institute Noninvasive Vaccination Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Noninvasive Vaccination Basic Information
9.5.2 Serum Institute Noninvasive Vaccination Product Overview
9.5.3 Serum Institute Noninvasive Vaccination Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Noninvasive Vaccination Basic Information
9.6.2 Valneva Noninvasive Vaccination Product Overview
9.6.3 Valneva Noninvasive Vaccination Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Noninvasive Vaccination Basic Information
9.7.2 Shanghai United Cell Noninvasive Vaccination Product Overview
9.7.3 Shanghai United Cell Noninvasive Vaccination Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Noninvasive Vaccination Basic Information
9.8.2 Bibcol Noninvasive Vaccination Product Overview
9.8.3 Bibcol Noninvasive Vaccination Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Noninvasive Vaccination Basic Information
9.9.2 PaxVax Noninvasive Vaccination Product Overview
9.9.3 PaxVax Noninvasive Vaccination Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Noninvasive Vaccination Basic Information
9.10.2 Vabiotech Noninvasive Vaccination Product Overview
9.10.3 Vabiotech Noninvasive Vaccination Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Noninvasive Vaccination Basic Information
9.11.2 Tiantan Biological Noninvasive Vaccination Product Overview
9.11.3 Tiantan Biological Noninvasive Vaccination Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Noninvasive Vaccination Basic Information
9.12.2 EuBiologics Noninvasive Vaccination Product Overview
9.12.3 EuBiologics Noninvasive Vaccination Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Noninvasive Vaccination Basic Information
9.13.2 Panacea Biotec Ltd Noninvasive Vaccination Product Overview
9.13.3 Panacea Biotec Ltd Noninvasive Vaccination Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Noninvasive Vaccination Basic Information
9.14.2 Bio-Med Noninvasive Vaccination Product Overview
9.14.3 Bio-Med Noninvasive Vaccination Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
9.16 AstraZeneca
9.16.1 AstraZeneca Noninvasive Vaccination Basic Information
9.16.2 AstraZeneca Noninvasive Vaccination Product Overview
9.16.3 AstraZeneca Noninvasive Vaccination Product Market Performance
9.16.4 AstraZeneca Business Overview
9.16.5 AstraZeneca Recent Developments
9.17 Cipla
9.17.1 Cipla Noninvasive Vaccination Basic Information
9.17.2 Cipla Noninvasive Vaccination Product Overview
9.17.3 Cipla Noninvasive Vaccination Product Market Performance
9.17.4 Cipla Business Overview
9.17.5 Cipla Recent Developments
9.18 BCHT
9.18.1 BCHT Noninvasive Vaccination Basic Information
9.18.2 BCHT Noninvasive Vaccination Product Overview
9.18.3 BCHT Noninvasive Vaccination Product Market Performance
9.18.4 BCHT Business Overview
9.18.5 BCHT Recent Developments
10 NONINVASIVE VACCINATION MARKET FORECAST BY REGION
10.1 Global Noninvasive Vaccination Market Size Forecast
10.2 Global Noninvasive Vaccination Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Noninvasive Vaccination Market Size Forecast by Country
10.2.3 Asia Pacific Noninvasive Vaccination Market Size Forecast by Region
10.2.4 South America Noninvasive Vaccination Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Vaccination by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Noninvasive Vaccination Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Noninvasive Vaccination by Type (2025-2030)
11.1.2 Global Noninvasive Vaccination Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Noninvasive Vaccination by Type (2025-2030)
11.2 Global Noninvasive Vaccination Market Forecast by Application (2025-2030)
11.2.1 Global Noninvasive Vaccination Sales (Kilotons) Forecast by Application
11.2.2 Global Noninvasive Vaccination Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Noninvasive Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Noninvasive Vaccination Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Noninvasive Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Noninvasive Vaccination Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Noninvasive Vaccination Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Vaccination as of 2022)
Table 10. Global Market Noninvasive Vaccination Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Noninvasive Vaccination Sales Sites and Area Served
Table 12. Manufacturers Noninvasive Vaccination Product Type
Table 13. Global Noninvasive Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Noninvasive Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Noninvasive Vaccination Market Challenges
Table 22. Global Noninvasive Vaccination Sales by Type (Kilotons)
Table 23. Global Noninvasive Vaccination Market Size by Type (M USD)
Table 24. Global Noninvasive Vaccination Sales (Kilotons) by Type (2019-2024)
Table 25. Global Noninvasive Vaccination Sales Market Share by Type (2019-2024)
Table 26. Global Noninvasive Vaccination Market Size (M USD) by Type (2019-2024)
Table 27. Global Noninvasive Vaccination Market Size Share by Type (2019-2024)
Table 28. Global Noninvasive Vaccination Price (USD/Ton) by Type (2019-2024)
Table 29. Global Noninvasive Vaccination Sales (Kilotons) by Application
Table 30. Global Noninvasive Vaccination Market Size by Application
Table 31. Global Noninvasive Vaccination Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Noninvasive Vaccination Sales Market Share by Application (2019-2024)
Table 33. Global Noninvasive Vaccination Sales by Application (2019-2024) & (M USD)
Table 34. Global Noninvasive Vaccination Market Share by Application (2019-2024)
Table 35. Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2024)
Table 36. Global Noninvasive Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Noninvasive Vaccination Sales Market Share by Region (2019-2024)
Table 38. North America Noninvasive Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Noninvasive Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Noninvasive Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Noninvasive Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Noninvasive Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Noninvasive Vaccination Basic Information
Table 44. Merck Noninvasive Vaccination Product Overview
Table 45. Merck Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Noninvasive Vaccination SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Noninvasive Vaccination Basic Information
Table 50. GSK Noninvasive Vaccination Product Overview
Table 51. GSK Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Noninvasive Vaccination SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Noninvasive Vaccination Basic Information
Table 56. Sanofi Noninvasive Vaccination Product Overview
Table 57. Sanofi Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Noninvasive Vaccination SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute Noninvasive Vaccination Basic Information
Table 62. Lanzhou Institute Noninvasive Vaccination Product Overview
Table 63. Lanzhou Institute Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute Business Overview
Table 65. Lanzhou Institute Recent Developments
Table 66. Serum Institute Noninvasive Vaccination Basic Information
Table 67. Serum Institute Noninvasive Vaccination Product Overview
Table 68. Serum Institute Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute Business Overview
Table 70. Serum Institute Recent Developments
Table 71. Valneva Noninvasive Vaccination Basic Information
Table 72. Valneva Noninvasive Vaccination Product Overview
Table 73. Valneva Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Valneva Business Overview
Table 75. Valneva Recent Developments
Table 76. Shanghai United Cell Noninvasive Vaccination Basic Information
Table 77. Shanghai United Cell Noninvasive Vaccination Product Overview
Table 78. Shanghai United Cell Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai United Cell Business Overview
Table 80. Shanghai United Cell Recent Developments
Table 81. Bibcol Noninvasive Vaccination Basic Information
Table 82. Bibcol Noninvasive Vaccination Product Overview
Table 83. Bibcol Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bibcol Business Overview
Table 85. Bibcol Recent Developments
Table 86. PaxVax Noninvasive Vaccination Basic Information
Table 87. PaxVax Noninvasive Vaccination Product Overview
Table 88. PaxVax Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. PaxVax Business Overview
Table 90. PaxVax Recent Developments
Table 91. Vabiotech Noninvasive Vaccination Basic Information
Table 92. Vabiotech Noninvasive Vaccination Product Overview
Table 93. Vabiotech Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vabiotech Business Overview
Table 95. Vabiotech Recent Developments
Table 96. Tiantan Biological Noninvasive Vaccination Basic Information
Table 97. Tiantan Biological Noninvasive Vaccination Product Overview
Table 98. Tiantan Biological Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Tiantan Biological Business Overview
Table 100. Tiantan Biological Recent Developments
Table 101. EuBiologics Noninvasive Vaccination Basic Information
Table 102. EuBiologics Noninvasive Vaccination Product Overview
Table 103. EuBiologics Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. EuBiologics Business Overview
Table 105. EuBiologics Recent Developments
Table 106. Panacea Biotec Ltd Noninvasive Vaccination Basic Information
Table 107. Panacea Biotec Ltd Noninvasive Vaccination Product Overview
Table 108. Panacea Biotec Ltd Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Panacea Biotec Ltd Business Overview
Table 110. Panacea Biotec Ltd Recent Developments
Table 111. Bio-Med Noninvasive Vaccination Basic Information
Table 112. Bio-Med Noninvasive Vaccination Product Overview
Table 113. Bio-Med Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bio-Med Business Overview
Table 115. Bio-Med Recent Developments
Table 116. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Basic Information
Table 117. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Overview
Table 118. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Halfkin Bio-Pharmaceuticals Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Recent Developments
Table 121. AstraZeneca Noninvasive Vaccination Basic Information
Table 122. AstraZeneca Noninvasive Vaccination Product Overview
Table 123. AstraZeneca Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. AstraZeneca Business Overview
Table 125. AstraZeneca Recent Developments
Table 126. Cipla Noninvasive Vaccination Basic Information
Table 127. Cipla Noninvasive Vaccination Product Overview
Table 128. Cipla Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Cipla Business Overview
Table 130. Cipla Recent Developments
Table 131. BCHT Noninvasive Vaccination Basic Information
Table 132. BCHT Noninvasive Vaccination Product Overview
Table 133. BCHT Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. BCHT Business Overview
Table 135. BCHT Recent Developments
Table 136. Global Noninvasive Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Noninvasive Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Noninvasive Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Noninvasive Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Noninvasive Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Noninvasive Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Noninvasive Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Noninvasive Vaccination Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Noninvasive Vaccination Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Noninvasive Vaccination Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Noninvasive Vaccination Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Noninvasive Vaccination Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Noninvasive Vaccination Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Noninvasive Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Noninvasive Vaccination Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Noninvasive Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Noninvasive Vaccination Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Noninvasive Vaccination Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Noninvasive Vaccination as of 2022)
Table 10. Global Market Noninvasive Vaccination Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Noninvasive Vaccination Sales Sites and Area Served
Table 12. Manufacturers Noninvasive Vaccination Product Type
Table 13. Global Noninvasive Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Noninvasive Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Noninvasive Vaccination Market Challenges
Table 22. Global Noninvasive Vaccination Sales by Type (Kilotons)
Table 23. Global Noninvasive Vaccination Market Size by Type (M USD)
Table 24. Global Noninvasive Vaccination Sales (Kilotons) by Type (2019-2024)
Table 25. Global Noninvasive Vaccination Sales Market Share by Type (2019-2024)
Table 26. Global Noninvasive Vaccination Market Size (M USD) by Type (2019-2024)
Table 27. Global Noninvasive Vaccination Market Size Share by Type (2019-2024)
Table 28. Global Noninvasive Vaccination Price (USD/Ton) by Type (2019-2024)
Table 29. Global Noninvasive Vaccination Sales (Kilotons) by Application
Table 30. Global Noninvasive Vaccination Market Size by Application
Table 31. Global Noninvasive Vaccination Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Noninvasive Vaccination Sales Market Share by Application (2019-2024)
Table 33. Global Noninvasive Vaccination Sales by Application (2019-2024) & (M USD)
Table 34. Global Noninvasive Vaccination Market Share by Application (2019-2024)
Table 35. Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2024)
Table 36. Global Noninvasive Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Noninvasive Vaccination Sales Market Share by Region (2019-2024)
Table 38. North America Noninvasive Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Noninvasive Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Noninvasive Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Noninvasive Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Noninvasive Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Noninvasive Vaccination Basic Information
Table 44. Merck Noninvasive Vaccination Product Overview
Table 45. Merck Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Noninvasive Vaccination SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Noninvasive Vaccination Basic Information
Table 50. GSK Noninvasive Vaccination Product Overview
Table 51. GSK Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Noninvasive Vaccination SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Noninvasive Vaccination Basic Information
Table 56. Sanofi Noninvasive Vaccination Product Overview
Table 57. Sanofi Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Noninvasive Vaccination SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute Noninvasive Vaccination Basic Information
Table 62. Lanzhou Institute Noninvasive Vaccination Product Overview
Table 63. Lanzhou Institute Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute Business Overview
Table 65. Lanzhou Institute Recent Developments
Table 66. Serum Institute Noninvasive Vaccination Basic Information
Table 67. Serum Institute Noninvasive Vaccination Product Overview
Table 68. Serum Institute Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute Business Overview
Table 70. Serum Institute Recent Developments
Table 71. Valneva Noninvasive Vaccination Basic Information
Table 72. Valneva Noninvasive Vaccination Product Overview
Table 73. Valneva Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Valneva Business Overview
Table 75. Valneva Recent Developments
Table 76. Shanghai United Cell Noninvasive Vaccination Basic Information
Table 77. Shanghai United Cell Noninvasive Vaccination Product Overview
Table 78. Shanghai United Cell Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai United Cell Business Overview
Table 80. Shanghai United Cell Recent Developments
Table 81. Bibcol Noninvasive Vaccination Basic Information
Table 82. Bibcol Noninvasive Vaccination Product Overview
Table 83. Bibcol Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bibcol Business Overview
Table 85. Bibcol Recent Developments
Table 86. PaxVax Noninvasive Vaccination Basic Information
Table 87. PaxVax Noninvasive Vaccination Product Overview
Table 88. PaxVax Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. PaxVax Business Overview
Table 90. PaxVax Recent Developments
Table 91. Vabiotech Noninvasive Vaccination Basic Information
Table 92. Vabiotech Noninvasive Vaccination Product Overview
Table 93. Vabiotech Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vabiotech Business Overview
Table 95. Vabiotech Recent Developments
Table 96. Tiantan Biological Noninvasive Vaccination Basic Information
Table 97. Tiantan Biological Noninvasive Vaccination Product Overview
Table 98. Tiantan Biological Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Tiantan Biological Business Overview
Table 100. Tiantan Biological Recent Developments
Table 101. EuBiologics Noninvasive Vaccination Basic Information
Table 102. EuBiologics Noninvasive Vaccination Product Overview
Table 103. EuBiologics Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. EuBiologics Business Overview
Table 105. EuBiologics Recent Developments
Table 106. Panacea Biotec Ltd Noninvasive Vaccination Basic Information
Table 107. Panacea Biotec Ltd Noninvasive Vaccination Product Overview
Table 108. Panacea Biotec Ltd Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Panacea Biotec Ltd Business Overview
Table 110. Panacea Biotec Ltd Recent Developments
Table 111. Bio-Med Noninvasive Vaccination Basic Information
Table 112. Bio-Med Noninvasive Vaccination Product Overview
Table 113. Bio-Med Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bio-Med Business Overview
Table 115. Bio-Med Recent Developments
Table 116. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Basic Information
Table 117. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Product Overview
Table 118. Halfkin Bio-Pharmaceuticals Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Halfkin Bio-Pharmaceuticals Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Recent Developments
Table 121. AstraZeneca Noninvasive Vaccination Basic Information
Table 122. AstraZeneca Noninvasive Vaccination Product Overview
Table 123. AstraZeneca Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. AstraZeneca Business Overview
Table 125. AstraZeneca Recent Developments
Table 126. Cipla Noninvasive Vaccination Basic Information
Table 127. Cipla Noninvasive Vaccination Product Overview
Table 128. Cipla Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Cipla Business Overview
Table 130. Cipla Recent Developments
Table 131. BCHT Noninvasive Vaccination Basic Information
Table 132. BCHT Noninvasive Vaccination Product Overview
Table 133. BCHT Noninvasive Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. BCHT Business Overview
Table 135. BCHT Recent Developments
Table 136. Global Noninvasive Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Noninvasive Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Noninvasive Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Noninvasive Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Noninvasive Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Noninvasive Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Noninvasive Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Noninvasive Vaccination Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Noninvasive Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Noninvasive Vaccination Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Noninvasive Vaccination Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Noninvasive Vaccination Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Noninvasive Vaccination Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Noninvasive Vaccination Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Noninvasive Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Noninvasive Vaccination Market Size (M USD), 2019-2030
Figure 5. Global Noninvasive Vaccination Market Size (M USD) (2019-2030)
Figure 6. Global Noninvasive Vaccination Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Noninvasive Vaccination Market Size by Country (M USD)
Figure 11. Noninvasive Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Noninvasive Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Noninvasive Vaccination Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Noninvasive Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Noninvasive Vaccination Market Share by Type
Figure 18. Sales Market Share of Noninvasive Vaccination by Type (2019-2024)
Figure 19. Sales Market Share of Noninvasive Vaccination by Type in 2023
Figure 20. Market Size Share of Noninvasive Vaccination by Type (2019-2024)
Figure 21. Market Size Market Share of Noninvasive Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Noninvasive Vaccination Market Share by Application
Figure 24. Global Noninvasive Vaccination Sales Market Share by Application (2019-2024)
Figure 25. Global Noninvasive Vaccination Sales Market Share by Application in 2023
Figure 26. Global Noninvasive Vaccination Market Share by Application (2019-2024)
Figure 27. Global Noninvasive Vaccination Market Share by Application in 2023
Figure 28. Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2024)
Figure 29. Global Noninvasive Vaccination Sales Market Share by Region (2019-2024)
Figure 30. North America Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Noninvasive Vaccination Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Noninvasive Vaccination Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Noninvasive Vaccination Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Noninvasive Vaccination Sales Market Share by Region in 2023
Figure 44. China Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Noninvasive Vaccination Sales and Growth Rate (Kilotons)
Figure 50. South America Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Noninvasive Vaccination Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Noninvasive Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Noninvasive Vaccination Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Noninvasive Vaccination Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Noninvasive Vaccination Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Noninvasive Vaccination Market Share Forecast by Type (2025-2030)
Figure 65. Global Noninvasive Vaccination Sales Forecast by Application (2025-2030)
Figure 66. Global Noninvasive Vaccination Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Noninvasive Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Noninvasive Vaccination Market Size (M USD), 2019-2030
Figure 5. Global Noninvasive Vaccination Market Size (M USD) (2019-2030)
Figure 6. Global Noninvasive Vaccination Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Noninvasive Vaccination Market Size by Country (M USD)
Figure 11. Noninvasive Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Noninvasive Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Noninvasive Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Noninvasive Vaccination Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Noninvasive Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Noninvasive Vaccination Market Share by Type
Figure 18. Sales Market Share of Noninvasive Vaccination by Type (2019-2024)
Figure 19. Sales Market Share of Noninvasive Vaccination by Type in 2023
Figure 20. Market Size Share of Noninvasive Vaccination by Type (2019-2024)
Figure 21. Market Size Market Share of Noninvasive Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Noninvasive Vaccination Market Share by Application
Figure 24. Global Noninvasive Vaccination Sales Market Share by Application (2019-2024)
Figure 25. Global Noninvasive Vaccination Sales Market Share by Application in 2023
Figure 26. Global Noninvasive Vaccination Market Share by Application (2019-2024)
Figure 27. Global Noninvasive Vaccination Market Share by Application in 2023
Figure 28. Global Noninvasive Vaccination Sales Growth Rate by Application (2019-2024)
Figure 29. Global Noninvasive Vaccination Sales Market Share by Region (2019-2024)
Figure 30. North America Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Noninvasive Vaccination Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Noninvasive Vaccination Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Noninvasive Vaccination Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Noninvasive Vaccination Sales Market Share by Region in 2023
Figure 44. China Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Noninvasive Vaccination Sales and Growth Rate (Kilotons)
Figure 50. South America Noninvasive Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Noninvasive Vaccination Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Noninvasive Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Noninvasive Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Noninvasive Vaccination Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Noninvasive Vaccination Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Noninvasive Vaccination Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Noninvasive Vaccination Market Share Forecast by Type (2025-2030)
Figure 65. Global Noninvasive Vaccination Sales Forecast by Application (2025-2030)
Figure 66. Global Noninvasive Vaccination Market Share Forecast by Application (2025-2030)
